RT Journal Article
SR Electronic
T1 Metabolic Disturbances, Hemoglobin A1c, and Social Cognition Impairment in Schizophrenia Spectrum Disorders
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.04.01.22273310
DO 10.1101/2022.04.01.22273310
A1 Tang, Sunny X.
A1 Oliver, Lindsay D.
A1 Hänsel, Katrin
A1 DeRosse, Pamela
A1 John, Majnu
A1 Khairullah, Ammar
A1 Gold, James M.
A1 Buchanan, Robert W.
A1 Voineskos, Aristotle
A1 Malhotra, Anil K.
YR 2022
UL http://medrxiv.org/content/early/2022/04/01/2022.04.01.22273310.abstract
AB Social cognitive impairments are core features of schizophrenia spectrum disorders (SSD) and are associated with greater functional impairment and decreased quality of life. Metabolic disturbances have been related to greater impairment in general neurocognition, but their relationship to social cognition has not been previously reported. In this study, metabolic measures and social cognition were assessed in 245 participants with SSD and 165 healthy comparison subjects (HC), excluding those with hemoglobin A1c (HA1c)>6.5%. Tasks assessed emotion processing, theory of mind, and social perception. Functional connectivity within and between social cognitive networks was measured during a naturalistic social task. Among SSD, a significant inverse relationship was found between social cognition and cumulative metabolic burden (β=-0.38, p<0.001) and HA1c (β=-0.37, p<0.001). The relationship between social cognition and HA1c was robust across domains and measures of social cognition and after accounting for age, sex, race, non-social neurocognition, hospitalization, and treatment with different antipsychotic medications. Negative connectivity between affect sharing and motor resonance networks was a partial mediator of this relationship across SSD and HC groups (β=-0.05, p=0.008). There was a group x HA1c effect indicating that SSD participants were more adversely affected by increasing HA1c. Thus, we provide the first report of a robust relationship in SSD between social cognition and abnormal glucose metabolism. If replicated and found to be causal, insulin sensitivity and blood glucose may present as promising targets for improving social cognition, functional outcomes, and quality of life in SSD.Competing Interest StatementSXT is a consultant for Neurocrine Biosciences and North Shore Therapeutics, received funding from Winterlight Labs, and holds equity in North Shore Therapeutics. RWB is a DSMB member for Merck, Newron, and Roche; on the advisory board for Acadia, Avanir, Boehringer Ingelheim GBMH, GW Pharma, Minerva, and Roche; and consultant for Boehringer Ingelheim GMBH. AKM is a consultant for Acadia Pharmaceuticals, Genomind Inc, Informed DNA, and Janssen Pharmaceuticals. The other authors have no disclosures to report.Funding StatementFunding was received from NIMH, R01MH102313.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The IRB's of the Feinstein Institutes for Medical Research, the Centre for Addiction and Mental Health, and the University of Maryland gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.